Enterprise Value
-2.584M
Cash
44.73M
Avg Qtr Burn
-6.507M
Short % of Float
0.38%
Insider Ownership
1.25%
Institutional Own.
1.29%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sulopenem Details Urinary tract infection | Phase 3 Data readout | |
Sulopenem Details Intra-abdominal infections | Failed Discontinued | |
Sulopenem Details Urinary tract infection | Failed Discontinued |